Phenotype | Gene(s) | Key reference(s) |
IPF, DKC | TERT, TERC, TINF2, PARN, NAF1, RTEL1, DKC1 | [111] |
IPF, lung cancer, CPFE, alveolar proteinosis | SFTPA1, SFTPA2, SFTPC, ABCA3 | [49, 50, 52, 56] |
Lung brain thyroid syndrome | NKX2.1 (TITF1) | [1, 59] |
Hermansky–Pudlak syndrome | HPS1–HSP8, AP3B1 | [112] |
Alveolar proteinosis | CSF2RA, CSF2RB, GATA2, MARS | [113–115] |
Lysinuric protein intolerance | SLC7A7 | [116] |
Pulmonary alveolar microlithiasis | SLC34A2 | [117] |
Gaucher's disease | GBA | [118] |
Niemann–Pick disease | SMPD1 | [119] |
Fabry disease | GLA | [120] |
STING-associated vasculopathy with onset in infancy | TMEM173, COPA | [121–123] |
Poikilodermia lung fibrosis | FAM111B | [124] |
Acadian variant of Fanconi syndrome | NDUFAF6 | [125] |
Prolidase deficiency | PEPD | [126] |
IPF: idiopathic pulmonary fibrosis; DKC: dyskeratosis congenita; CPFE: combined pulmonary fibrosis and emphysema; STING: stimulator of interferon genes.